Research programme: small-molecule MANF mimetics - Amarantus Bioscience Holdings
Latest Information Update: 25 Aug 2014
At a glance
- Originator Amarantus Bioscience Holdings
- Class Small molecules
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Neurological disorders
Most Recent Events
- 21 Jul 2014 Early research in Neurological disorders in USA (unspecified route)